| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology.
|
Clin Nutr
|
2006
|
2.89
|
|
2
|
Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase.
|
Mol Cell Biol
|
1991
|
2.47
|
|
3
|
Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.
|
J Antimicrob Chemother
|
1995
|
2.22
|
|
4
|
Expression of two novel eph-related receptor protein tyrosine kinases in mammary gland development and carcinogenesis.
|
Oncogene
|
1994
|
1.51
|
|
5
|
Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.
|
Br J Clin Pharmacol
|
1995
|
1.09
|
|
6
|
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans.
|
Clin Pharmacol Ther
|
1995
|
1.06
|
|
7
|
Rapid and sensitive single-step radiochemical assay for catechol-O-methyltransferase.
|
J Neurochem
|
1982
|
1.06
|
|
8
|
On tyramine, food, beverages and the reversible MAO inhibitor moclobemide.
|
J Neural Transm Suppl
|
1988
|
0.97
|
|
9
|
Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjects.
|
Eur J Clin Pharmacol
|
1996
|
0.92
|
|
10
|
Characterization of a novel murine testis-specific serine/threonine kinase.
|
Gene
|
1994
|
0.92
|
|
11
|
Optimizing levodopa pharmacokinetics with multiple tolcapone doses in the elderly.
|
Clin Pharmacol Ther
|
1997
|
0.92
|
|
12
|
Bioavailability of L-dopa after Madopar HBS administration in healthy volunteers.
|
Eur Neurol
|
1987
|
0.92
|
|
13
|
Molecular characterization of the murine syk protein tyrosine kinase cDNA, transcripts and protein.
|
Biochem Biophys Res Commun
|
1995
|
0.90
|
|
14
|
Pharmacokinetic-pharmacodynamic interactions between two selective monoamine oxidase inhibitors: moclobemide and selegiline.
|
Clin Neuropharmacol
|
1996
|
0.89
|
|
15
|
Structure-based design, synthesis, and in vitro evaluation of bisubstrate inhibitors for catechol O-methyltransferase (COMT).
|
Chemistry
|
2000
|
0.87
|
|
16
|
iyk, a novel intracellular protein tyrosine kinase differentially expressed in the mouse mammary gland and intestine.
|
Biochem Biophys Res Commun
|
1995
|
0.86
|
|
17
|
The effect of COMT inhibition by tolcapone on tolerability and pharmacokinetics of different levodopa/benserazide formulations.
|
Eur Neurol
|
1997
|
0.86
|
|
18
|
Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.
|
Br J Clin Pharmacol
|
1997
|
0.85
|
|
19
|
Intestinal absorption of levodopa in man.
|
Eur J Clin Pharmacol
|
1983
|
0.85
|
|
20
|
Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line.
|
J Neurochem
|
1992
|
0.83
|
|
21
|
Pharmacokinetics and pharmacodynamics after oral and intravenous administration of tolcapone, a novel adjunct to Parkinson's disease therapy.
|
Eur J Clin Pharmacol
|
1998
|
0.83
|
|
22
|
Effects of tolcapone, a novel catechol-O-methyltransferase inhibitor, on striatal metabolism of L-dopa and dopamine in rats.
|
Eur J Pharmacol
|
1995
|
0.83
|
|
23
|
Simultaneous determination of histamine and N alpha-methylhistamine in biological samples by an improved enzymatic single isotope assay.
|
Agents Actions
|
1985
|
0.82
|
|
24
|
Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
|
Eur Neurol
|
1987
|
0.82
|
|
25
|
Investigation of a correlation between monoamine oxidase B and catechol-O-methyltransferase activity in human blood cells.
|
Eur J Pharm Sci
|
2000
|
0.81
|
|
26
|
Radioenzymatic assay of femtomole concentrations of DOPA in tissues and body fluids.
|
J Neurochem
|
1979
|
0.78
|
|
27
|
Immunoaffinity purification and partial amino acid sequence analysis of catechol-O-methyltransferase from pig liver.
|
Biochim Biophys Acta
|
1991
|
0.76
|
|
28
|
Monoclonal antibodies recognizing both soluble and membrane bound catechol-O-methyltransferase.
|
J Neural Transm Suppl
|
1990
|
0.75
|
|
29
|
Tyramine content of preserved and fermented foods or condiments of Far Eastern cuisine.
|
Psychopharmacology (Berl)
|
1992
|
0.75
|
|
30
|
Mosé Da Prada and the discovery of tolcapone.
|
J Neural Transm Suppl
|
1998
|
0.75
|
|
31
|
Tyrosine kinases: from viral oncogenes to developmental regulators.
|
Behring Inst Mitt
|
1991
|
0.75
|
|
32
|
Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B.
|
Neurosci Lett
|
1985
|
0.75
|
|
33
|
Clinical, pharmacokinetic, and pharmacodynamic effects of tolcapone withdrawal in levodopa-treated patients with parkinsonism.
|
Clin Neuropharmacol
|
2000
|
0.75
|